Surbhi Shah, MBBS
I am a clinician, researcher, and educator with a focus on non-malignant hematology and special interest in thrombosis. I strive to provide passionate care to patients with benign hematological disorders and lead system wide efforts to minimize clinical practice variation in our large academic health care system so patients can receive uniform care no matter where they are. I believe that the foundations of future clinicians are laid in pre-clinical years and lead the hematology course for medical students, I am also actively engaged in teaching and mentoring medical students, residents and fellows. I do outcomes and implementation research with a focus on thrombotic complications in high risk groups particularly cancer, obesity, bariatric surgery, post thrombotic syndrome etc.
Expertise
- Anemia
- Disorders of White Blood Cells
- Disorders of platelets
- Coagulation defects
- Clotting disorders
- Bleeding disorders
Professional Associations
- Member, International Society on Thrombosis and Hemostasis
- Member, Hemostasis and Thrombosis Research Society
- Member, American Society of Hematology
- Member, American Society of Clinical Oncology
- ASH system based hematology-working group present
- COVID 19 Cancer consortium CCC19 thrombosis working group
- Member, Quality improvement collaborative team
- Member, System based hematology initiatives for COVID19
Languages
- English
- Hindi
Education
Assistant Professor of Medicine, Division of Hematology, Oncology and Transplantation
Director, Hematology Course, 2nd Year Medical School Hematology Curriculum
Hematology Lead, AAMC Core e-consults Program
MD, Medical School, Jawaharlal Nehru Medical College, Aligarh, India
Residency, Hennepin County Medical Center, Minneapolis, Minnesota
Fellowship, University of Minnesota, Minneapolis, Minnesota
Research
Research Summary/Interests
Outcomes research in various hematological and oncology disorders
Publications
- Solh M, Mescher C, Klappa A, Shah S, Zantek N, Datta Y. Acquired Glanzmann's thrombasthenia with optimal response to rituximab therapy. American Journal of Hematology. 2011; 86(8):715-6.
- Shahid M, Siddiqui FA, Mubeen A, Shah S, Sherwani RK. The role of sediment cytology in ovarian neoplasm. Acta Cytol.2011; 55(3):261-5
- Shah S, Rehman K, Siddiqui F, Akhtar K, Zaheer S, Sherwani R. Bone lesions: Role of sediment cytology. Diagnostic Cytopathology. 2009; 37(6): 397-401
Teaching
Academic Interests and Focus
Curriculum development for medical student education
Clinical
Clinical Interests
Anemia; Disorders of White Blood Cells; Disorders of platelets; Coagulation defects; Clotting disorders; Bleeding disorders